Current and future direction in treatment of HPV-related cervical disease

Human papillomavirus (HPV) is the most common sexually transmitted virus in the world. About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and 18. Since available prophylactic vaccines do not induce immunity in those with established HPV infections, the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Khairkhah, Niloofar, Bolhassani, Azam, Najafipour, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045016/
https://www.ncbi.nlm.nih.gov/pubmed/35478255
http://dx.doi.org/10.1007/s00109-022-02199-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045016/
https://www.ncbi.nlm.nih.gov/pubmed/35478255
http://dx.doi.org/10.1007/s00109-022-02199-y

Ejemplares similares